Median Technologies has updated its Median LMS (Lesion Management Solution) software toevaluate, follow and report on changes involving of cancerous lesions seen on CT images from the neck to the pelvis.
Median Technologies has updated its Median LMS (Lesion Management Solution) software to
evaluate, follow and report on changes involving of cancerous lesions seen on CT images from the neck to the pelvis. The enhanced software, slated to debut at RSNA 2009, generates a single report for the quantitative management of patient response to therapy, according to the company. It is designed for routine clinical use, as well as in multicenter clinical trials. Median LMS automates the initial evaluation and follow-up of cancerous lesions identified in CT images of the thorax, abdomen and pelvis, automatically generating a standardized oncologic report and centralizing all lesion information. In so doing, it helps in the assessment of patient response to therapy, assisting in an evaluation of the effectiveness drugs. This can be especially important in clinical trials, when experimental drugs require standardized measurement and reporting of target lesion response, according to the company.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.